Menu
sharewise sharewise
Log in
Sign up
Log in
Sign up
Microsoft strongly encourages users to switch to a different browser than Internet Explorer as it no longer meets modern web and security standards. Therefore we cannot guarantee that our site fully works in Internet Explorer. You can use Chrome or Firefox instead.
  1. Predictions
buy

Acadia Pharmaceuticals buy UBS Group AG

Acadia Pharmaceuticals
Start price
€13.87
16:15 / 50%
Target price
€21.10
08.08.25
Performance (%)
-
Price
-
-
Summary
This prediction has just been started. It does not have a price yet.. This prediction currently runs until 08.08.25. The prediction end date can be changed by UBS_Group_AG at any time.
Performance without dividends (%)
Name 1w
Acadia Pharmaceuticals -
iShares Core DAX® -5.630%
iShares Nasdaq 100 -8.559%
iShares Nikkei 225® -9.576%
iShares S&P 500 -6.631%

Comments by UBS_Group_AG for this prediction

In the thread Acadia Pharmaceuticals diskutieren
Prediction Buy
Perf. (%) -
Target price 21.098
Change
Ends at 08.08.25

ACADIA Pharmaceuticals Inc. (NASDAQ: ACAD) had its price target lowered by analysts at UBS Group AG from $25.00 to $23.00. They now have a "buy" rating on the stock.
Ratings data for ACAD provided by MarketBeat

UBS Group AG 
0
Report Share
16:15

Stopped prediction by UBS_Group_AG for Acadia Pharmaceuticals

buy
Acadia Pharmaceuticals

Start price
Target price
Perf. (%)
€21.80
17.10.23
€31.28
17.10.24
-33.49%
07.08.24

UBS Group AG 
17.10.23 50%